The stock's overall trend over the past six months has been volatile but ultimately negative, declining 2.0% from October 2025 to March 2026. The price peaked near $27.10 in mid-February before a sharp correction. Over the short term, the stock has declined 0.4% over the past month but gained 3.1% over the past three months, significantly outperforming the S&P 500 which fell 4.63% over the same three-month period. The current price of $24.43 sits near the lower end of its 52-week range, positioned approximately 17.4% below its 52-week high of $29.59 and 15.5% above its 52-week low of $21.16.

Revenue and profitability have shown weakness, with Q4 2025 revenue of $1.54 billion representing a 9.8% year-over-year decline. The quarterly net margin was 4.8%, but the operating margin was negative at -1.1%, indicating pressure on core operations. The company maintains moderate financial health with a debt-to-equity ratio of 60.7% and a current ratio of 1.29, while generating positive free cash flow of $549 million over the trailing twelve months. Operational efficiency metrics are subdued, with a return on equity of 3.38% and a return on assets of 0.74%, reflecting challenges in generating strong returns from its asset base.